Antiseizure Drug Helps Optic Neuritis in Multiple Sclerosis
The relationship between seizures, optic neuritis, and multiple sclerosis may seem difficult to fathom, but the results of a new study shed some light on the subject. It appears that the common antiseizure drug called phenytoin has the ability to help ...
eMaxHealth - Thu, 23 Apr 2015 07:14

Seizure Medication Reduced Optic Neuritis In Multiple Sclerosis
Medical Research News and Interviews on MedicalResearch.com (blog) - Thu, 23 Apr 2015 12:52

Repurposed drug an eye opener for MS
6minutes - Wed, 22 Apr 2015 21:41



Biogen Reports New Data from Acute Optic Neuritis Study
Biogen (BIIB - Analyst Report) announced positive new data from the phase II RENEW study on anti-LINGO-1 for acute optic neuritis (AON). The company intends to present data from the study at the annual meeting of the American Academy of Neurology.
Zacks.com - Wed, 15 Apr 2015 14:12

Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data ...
Business Wire (press release) - Tue, 14 Apr 2015 13:03

Biogen Reports New Data from Acute Optic Neuritis Study - Analyst Blog
Nasdaq - Wed, 15 Apr 2015 14:11

Optic Neuritis - Pipeline Review, H1 2015
This report provides comprehensive information on the therapeutic development for Optic Neuritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and ...
Solar Plaza (press release) - Tue, 21 Apr 2015 09:07

AAN: Phenytoin Neuroprotective in Optic Neuritis
Raju Kapoor, M.D., from the National Hospital for Neurology and Neurosurgery in London, and colleagues conducted a phase 2 randomized trial involving 81 patients with AON. Participants were randomized within two weeks of symptom onset to receive ...
Doctors Lounge - Fri, 17 Apr 2015 09:52

Phenytoin May Have Applications for Multiple Sclerosis
Neurology Advisor - Fri, 17 Apr 2015 12:10

Phenytoin has neuroprotective effect suggests study
MS Trust - Fri, 17 Apr 2015 06:52

Global optic neuritis therapeutic pipeline market review and comparative ...
Complete report on H1 2015 pipeline review of Optic Neuritis with 22 market data tables and 13 figures, spread across 60 pages is available at http://www.rnrmarketresearch.com/optic-neuritis-pipeline-review-h1-2015-market-report.html . (This is a ...
WhaTech - Thu, 23 Apr 2015 14:45



Encouraging signs of myelin repair in optic neuritis drug trial
In a clinical trial of anti-LINGO-1, people with optic neuritis who took the new drug had improved nerve signals between the eye and the brain. A phase II clinical trial called RENEW tested a drug called BIIB033, which is anti-LINGO-1 agent, against ...
MS Trust - Wed, 15 Apr 2015 08:30

New Drug Shows Promise for MS
HealthDay - Tue, 14 Apr 2015 13:01

New drug could reverse the damage of multiple sclerosis
Telegraph.co.uk - Tue, 14 Apr 2015 13:03

Antibody That Repairs Nerve Damage Improves Visual Symptoms in MS Patients
Healthline - Wed, 15 Apr 2015 12:24



Optic Neuritis Therapeutic Development and Pipeline Market Review H1 2015 ...
The report “Optic Neuritis – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Optic Neuritis. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class ...
Virtual-Strategy Magazine (press release) - Wed, 22 Apr 2015 07:26

Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient ...
Seropositivity for anti-aquaporin-4 Abs (AQP-4-IgG) marks severe forms of optic neuritis (ON), which are part of the so-called neuromyelitis optica spectrum disorders (NMOSD), and can remain isolated or evolve into the complete phenotype of the ...
Nature.com - Mon, 27 Apr 2015 07:21


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014